HR 3160
Pharmaceutical Research Transparency Act of 2023
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Pharmaceutical Research Transparency Act of 2023 aims to increase public understanding of the costs associated with developing new drugs. It requires the National Institutes of Health to create a public database detailing the costs of clinical trials, including personnel, healthcare services, and other expenses. Additionally, the bill mandates that drug manufacturers disclose their research and development expenditures to the Securities and Exchange Commission, providing greater insight into the financial investment behind drug development.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.